Autism Diagnostics Target biology and early autism detection capabilities to seed partnerships with larger diagnostic labs and hospitals seeking expanded ASD testing menus.

Strategic Partners Leverage existing investor and academic collaborations to open co-development opportunities with major players in genetics and neurodevelopment, including potential channel partnerships.

Private Equity Fit Position as a scalable, cost-conscious innovator in a market dominated by larger firms, highlighting potential acquisition or minority investment discussions with mid and large cap diagnostic players.

Clinical Expansion Identify opportunities to broaden service offerings beyond autism to other neurodevelopmental and pediatric diagnostics to increase test volume and cross-sell to established clinical networks.

Digital Enablement Offer technology enablers such as lab workflow integration, secure data reporting, and customer-facing platforms to improve efficiency for partner laboratories and drive adoption.